MedVellum
MedVellum
Back to Library
Gastroenterology
Emergency Medicine
General Surgery
EMERGENCY

Acute Upper GI Bleeding

High EvidenceUpdated: 2025-12-25

On This Page

Red Flags

  • Hematemesis (vomiting blood)
  • Melena (black, tarry stools)
  • Hemodynamic instability (SBP <90 mmHg)
  • Heart rate >100 bpm
  • Altered mental status
  • Syncope or near-syncope
  • Active bleeding (ongoing hematemesis/melena)
Overview

Acute Upper GI Bleeding

1. Clinical Overview

Summary

Acute upper gastrointestinal bleeding is a medical emergency where bleeding occurs from the esophagus, stomach, or first part of the small intestine (duodenum). Picture your digestive tract as a series of pipes—when one springs a leak, blood can pour out rapidly, causing you to lose significant amounts of blood in a short time. Patients may vomit bright red blood (hematemesis) or pass black, tarry stools (melena) that look like tar and smell foul. This condition affects approximately 100-200 per 100,000 people annually and carries a mortality of 5-10% overall, rising to 30-40% in high-risk patients. The key to survival is rapid assessment, aggressive resuscitation, risk stratification using validated scores (like the Glasgow-Blatchford or Rockall scores), and urgent endoscopy to identify and treat the bleeding source. Most bleeds stop spontaneously, but those that don't require endoscopic, radiological, or surgical intervention.

Key Facts

  • Definition: Bleeding from GI tract proximal to ligament of Treitz (duodenal-jejunal junction)
  • Incidence: 100-200 per 100,000/year; ~50,000-100,000 hospitalizations/year (UK)
  • Mortality: 5-10% overall; 30-40% in high-risk patients
  • Time to endoscopy: Urgent (<24h) for high-risk, routine for low-risk
  • Critical threshold: Hemoglobin drop >2g/dL or need for >2 units blood
  • Key investigation: Urgent upper GI endoscopy (OGD)
  • First-line treatment: IV access, fluid resuscitation, PPI (omeprazole 80mg IV), urgent endoscopy

Clinical Pearls

"Hematemesis = Upper GI bleed" — Vomiting blood always indicates upper GI bleeding (above ligament of Treitz). Bright red = active bleeding; coffee-ground = old blood. Melena (black stools) also indicates upper GI source (blood takes time to turn black as it passes through).

"Resuscitate first, investigate second" — Don't delay resuscitation for endoscopy. Get IV access, start fluids, check bloods, then scope. A dead patient can't be scoped.

"Rockall score predicts mortality, Glasgow-Blatchford predicts need for intervention" — Use Rockall for prognosis, GBS for deciding who needs urgent endoscopy and admission.

"Most peptic ulcers stop bleeding on their own" — 80% stop spontaneously. Endoscopy is for the 20% that don't—identify high-risk stigmata (active bleeding, visible vessel) and treat endoscopically.

Why This Matters Clinically

Acute upper GI bleeding is a common emergency with significant mortality if not managed promptly. Rapid blood loss can lead to hypovolaemic shock and death within hours. The key is early recognition, aggressive resuscitation, and risk stratification to identify those needing urgent endoscopy versus those who can be managed conservatively. Delayed recognition or inappropriate management (like giving NSAIDs to someone with a bleeding ulcer) can be fatal. Protocol-driven management focusing on resuscitation, risk assessment, and timely endoscopy can reduce mortality significantly.


2. Epidemiology

Incidence & Prevalence

  • Overall: 100-200 per 100,000/year
  • UK: ~50,000-100,000 hospitalizations/year
  • US: ~300,000 hospitalizations/year
  • Trend: Decreasing (better H. pylori treatment, PPI use)
  • Peak age: 60-70 years

Demographics

FactorDetails
AgeMedian age 65 years; rare <40 unless varices or Mallory-Weiss
SexSlight male predominance (55:45)
EthnicityHigher rates in certain populations (H. pylori prevalence)
GeographyHigher in areas with high H. pylori prevalence
SettingEmergency departments, gastroenterology units

Risk Factors

Non-Modifiable:

  • Age >60 years
  • Male sex
  • Previous GI bleeding

Modifiable:

Risk FactorRelative RiskMechanism
NSAID use3-5xDirect mucosal damage
Antiplatelet agents2-3xAspirin, clopidogrel
Anticoagulants2-4xWarfarin, DOACs
H. pylori infection2-3xPeptic ulcer disease
Alcohol excess2-3xGastritis, varices
Smoking1.5-2xPeptic ulcer risk
Cirrhosis5-10xVarices, portal hypertension

Common Causes

CauseFrequencyTypical Patient
Peptic ulcer40-50%Older, NSAID use, H. pylori
Varices10-15%Cirrhosis, portal hypertension
Mallory-Weiss tear5-10%Young, alcohol, vomiting
Gastritis/erosions10-15%NSAID use, stress
Tumors2-5%Older, weight loss
Dieulafoy lesion1-2%Any age, recurrent bleeds
Aortoenteric fistulaRarePrevious aortic surgery

3. Pathophysiology

The Bleeding Cascade

Step 1: Underlying Pathology

  • Peptic ulcer: Erosion through mucosa into blood vessel
  • Varices: Portal hypertension → dilated veins → rupture
  • Mallory-Weiss: Forceful vomiting → mucosal tear
  • Gastritis: Inflammation → erosion → bleeding

Step 2: Vessel Exposure or Rupture

  • Ulcer: Erodes into submucosal vessel (artery or vein)
  • Varices: Thin-walled veins rupture under pressure
  • Tear: Disrupts mucosal vessels

Step 3: Hemorrhage

  • Arterial bleeding: Bright red, pulsatile, rapid
  • Venous bleeding: Darker, slower
  • Volume loss: Can be rapid (liters in minutes)

Step 4: Compensatory Mechanisms

  • Sympathetic activation: Tachycardia, vasoconstriction
  • Fluid shifts: Interstitial fluid moves to intravascular
  • Result: Temporary maintenance of BP

Step 5: Decompensation

  • If bleeding continues: Hypovolaemia → shock
  • If stops: Spontaneous hemostasis (80% of cases)

Classification by Bleeding Stigmata (Endoscopic)

StigmaRisk of RebleedingMortalityEndoscopic Treatment
Active spurting90%+HighUrgent endoscopic therapy
Visible vessel50%ModerateEndoscopic therapy
Adherent clot30%ModerateConsider endoscopic therapy
Flat spot10%LowUsually no treatment needed
Clean base<5%LowNo treatment needed

Anatomical Considerations

Upper GI Tract Anatomy:

  • Esophagus: 25cm long, can bleed from varices, tears, tumors
  • Stomach: Large capacity, can hold significant blood
  • Duodenum: First part (bulb) common site for ulcers
  • Ligament of Treitz: Anatomical landmark (duodenal-jejunal junction)

Why Some Sites Bleed More:

  • Gastric ulcers: Can erode into left gastric artery (large vessel)
  • Duodenal ulcers: Can erode into gastroduodenal artery
  • Varices: Thin walls, high pressure → rupture easily

4. Clinical Presentation

Symptoms: The Patient's Story

Typical Presentation:

Presentation by Cause:

Peptic Ulcer:

Varices:

Mallory-Weiss Tear:

Signs: What You See

Vital Signs (Critical):

SignFindingSignificance
Systolic BPLow (<90) or normalHypotension = significant blood loss
Heart rateTachycardia (>100)Compensatory response
Postural dropBP drops >20mmHg on standingSignificant volume loss
Respiratory rateMay be increasedCompensatory or anxiety

General Appearance:

Abdominal Examination:

Other Findings:

Red Flags

[!CAUTION] Red Flags — Immediate Escalation Required:

  • Hematemesis (vomiting blood) — Confirms upper GI bleeding
  • Melena (black, tarry stools) — Indicates upper GI source
  • Hemodynamic instability (SBP <90 mmHg) — Significant blood loss
  • Heart rate >100 bpm — Compensatory response to blood loss
  • Altered mental status — Severe hypovolaemia or liver disease
  • Syncope or near-syncope — Significant volume loss
  • Active bleeding (ongoing hematemesis/melena) — Needs urgent endoscopy
  • Postural hypotension — >20mmHg drop indicates volume depletion

Hematemesis
Vomiting blood Bright red: Active, recent bleeding Coffee-ground: Old blood, partially digested
Melena
Black, tarry stools Appearance: Shiny, sticky, foul-smelling Mechanism: Blood digested as it passes through gut
Weakness/dizziness
From blood loss
Syncope
If significant blood loss
Abdominal pain
May have epigastric pain (ulcer)
5. Clinical Examination

Structured Approach: ABCDE

A - Airway

  • Assessment: Usually patent
  • Finding: May have blood in mouth if recent hematemesis
  • Action: Clear airway if needed

B - Breathing

  • Look: Respiratory rate, use of accessory muscles
  • Listen: Usually normal (unless severe anemia)
  • Measure: SpO2 (usually normal unless severe)
  • Action: Oxygen if hypoxic or severe anemia

C - Circulation

  • Look: Skin colour (pale), capillary refill
  • Feel: Pulse (rate, volume), BP (lying and standing)
  • Listen: Heart sounds (tachycardia)
  • Measure: BP (both arms), HR, ECG
  • Action: IV access x2 (large bore), fluid resuscitation

D - Disability

  • Assessment: GCS, mental status
  • Finding: May be confused if hypovolaemic or liver disease
  • Action: Check glucose; consider if hypovolaemia causing confusion

E - Exposure

  • Look: Full body examination, look for stigmata of liver disease
  • Feel: Abdomen (tenderness, masses)
  • Action: PR examination (check for melena)

Specific Examination Findings

Cardiovascular Assessment:

Postural Blood Pressure:

  • Technique: Measure BP lying, then standing
  • Finding: Drop >20mmHg systolic = significant volume loss
  • Significance: Indicates need for fluid resuscitation

Pulse Assessment:

  • Rate: Tachycardia (compensatory)
  • Volume: Weak if significant blood loss
  • Rhythm: Usually regular (may be irregular if AF)

Abdominal Examination:

  • Inspection: Distension (if ascites), scars (previous surgery)
  • Palpation: Epigastric tenderness (ulcer), hepatosplenomegaly (liver disease)
  • Auscultation: Usually normal bowel sounds

Rectal Examination:

  • Purpose: Confirm melena, assess for lower GI bleeding
  • Finding: Black, tarry stool = melena (upper GI)
  • Note: Always do PR in GI bleeding

Special Tests

TestTechniquePositive FindingClinical Use
Postural BPMeasure lying, then standingDrop >20mmHgAssesses volume status
Capillary refillPress nail bed, release>2 secondsPoor perfusion
Shock indexHR/SBP>1.0Indicates shock

6. Investigations

First-Line (Bedside) - Do Immediately

1. Full Blood Count

  • Purpose: Assess blood loss
  • Finding:
    • Hemoglobin: May be normal initially (hemoconcentration), drops later
    • MCV: Normal (acute blood loss)
    • Platelets: May be low (liver disease, DIC)
  • Action: Repeat in 4-6 hours (true Hb will show)

2. Coagulation Studies

  • Purpose: Assess bleeding risk
  • Finding:
    • INR: May be elevated (liver disease, anticoagulants)
    • PT/APTT: Prolonged if liver disease
  • Action: Correct if possible (vitamin K, FFP)

3. Urea & Creatinine

  • Purpose: Assess renal function
  • Finding:
    • Urea: Often elevated (blood breakdown in gut)
    • Creatinine: Usually normal (unless CKD)
  • Note: Urea:Creatinine ratio >100 suggests upper GI bleeding

4. Liver Function Tests

  • Purpose: Assess for liver disease (varices risk)
  • Finding: May be abnormal if cirrhosis
  • Action: If abnormal, higher suspicion for varices

5. Group & Save / Crossmatch

  • Purpose: Prepare for transfusion
  • Action: Group & save if stable; crossmatch 4-6 units if unstable

Risk Stratification Scores

Glasgow-Blatchford Score (GBS):

ParameterScore
Hemoglobin (g/dL)
Men: >12.0 = 0, 10-12 = 1, 8-10 = 3, <8 = 6
Women: >10 = 0, 8-10 = 1, <8 = 6
Urea (mmol/L)
<6.5 = 0, 6.5-8 = 2, 8-10 = 3, 10-25 = 4, >25 = 6
Systolic BP
>109 = 0, 100-109 = 1, <100 = 2
Heart rate
<100 = 0, >100 = 1
Melena1
Syncope2
Liver disease2
Heart failure2

Interpretation:

  • GBS 0: Can be discharged (low risk)
  • GBS 1-2: Consider discharge if stable
  • GBS ≥3: Admit, consider urgent endoscopy

Rockall Score (Post-Endoscopy):

ParameterScore
Age<60 = 0, 60-79 = 1, ≥80 = 2
ShockNone = 0, Tachycardia = 1, Hypotension = 2
ComorbidityNone = 0, Major = 2, Liver/kidney failure = 3
DiagnosisMallory-Weiss = 0, All other = 1, Malignancy = 2
StigmataNone/clean base = 0, Blood/clot = 2, Spurting/vessel = 2

Interpretation:

  • Rockall 0-2: Low risk (mortality <5%)
  • Rockall 3-5: Moderate risk (mortality 10-15%)
  • Rockall ≥6: High risk (mortality >30%)

Imaging

Upper GI Endoscopy (OGD) - Essential

FindingSignificanceTreatment
Active bleedingSpurting or oozingUrgent endoscopic therapy
Visible vesselNon-bleeding visible vesselEndoscopic therapy
Adherent clotClot over ulcerConsider endoscopic therapy
Flat spotPigmented spotUsually no treatment
Clean baseHealed ulcerNo treatment needed

Timing:

  • Urgent (<24h): High-risk (GBS ≥3, active bleeding, unstable)
  • Routine (24-48h): Low-risk, stable

CT Angiography (If Endoscopy Unavailable/Contraindicated):

  • Indication: If cannot scope, or to locate source
  • Finding: May show bleeding site, vascular abnormalities
  • Note: Less sensitive than endoscopy

Diagnostic Criteria

Clinical Diagnosis:

  • Hematemesis: Vomiting blood (confirms upper GI)
  • Melena: Black, tarry stools (indicates upper GI)
  • Hemodynamic instability: Suggests significant blood loss

Severity Assessment:

  • Mild: Stable, GBS 0-2, no active bleeding
  • Moderate: Some instability, GBS 3-5, may have active bleeding
  • Severe: Unstable, GBS ≥6, active bleeding, high Rockall score

7. Management

Management Algorithm

        ACUTE UPPER GI BLEEDING PRESENTATION
    (Hematemesis or melena)
                    ↓
┌─────────────────────────────────────────────────┐
│         IMMEDIATE ASSESSMENT (&lt;5 mins)          │
│  • ABCDE approach                                │
│  • IV access (large bore x2)                    │
│  • Check FBC, U&Es, coagulation                 │
│  • Group & save / crossmatch                     │
│  • Calculate GBS score                          │
│  • Do NOT give oral intake                       │
└─────────────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────┐
│         RESUSCITATION                            │
│  • Fluid resuscitation (crystalloid)             │
│  • Blood transfusion if:                        │
│     - Hb &lt;70 g/L (or &lt;80 if cardiac disease)    │
│     - Active bleeding                            │
│     - Hemodynamic instability                    │
│  • Correct coagulation if possible               │
│  • PPI (omeprazole 80mg IV)                     │
└─────────────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────┐
│         RISK STRATIFICATION                      │
├─────────────────────────────────────────────────┤
│  LOW RISK (GBS 0-2, stable)                    │
│  → Consider discharge if:                       │
│     - No further bleeding                        │
│     - Hb stable                                  │
│     - Can follow up                              │
│  → Routine endoscopy (24-48h)                   │
│                                                  │
│  MODERATE RISK (GBS 3-5)                        │
│  → Admit to ward                                 │
│  → Urgent endoscopy (&lt;24h)                       │
│  → Monitor closely                               │
│                                                  │
│  HIGH RISK (GBS ≥6, unstable, active bleeding) │
│  → Admit to HDU/ICU                             │
│  → Urgent endoscopy (&lt;12h, ideally &lt;6h)         │
│  → Prepare for endoscopic therapy               │
│  → Consider interventional radiology/surgery    │
└─────────────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────┐
│         ENDOSCOPIC MANAGEMENT                    │
├─────────────────────────────────────────────────┤
│  ACTIVE BLEEDING or VISIBLE VESSEL              │
│  → Endoscopic therapy:                          │
│     - Injection (adrenaline)                    │
│     - Thermal (cautery, APC)                    │
│     - Mechanical (clips)                         │
│     - Combination (usually best)                 │
│                                                  │
│  ADHERENT CLOT                                  │
│  → Consider removing clot                       │
│  → Treat underlying stigmata                    │
│                                                  │
│  CLEAN BASE or FLAT SPOT                        │
│  → No endoscopic therapy needed                 │
│  → Medical management (PPI)                     │
└─────────────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────┐
│         POST-ENDOSCOPY MANAGEMENT                │
│  • High-dose PPI (omeprazole 80mg BD IV)        │
│  • Monitor for rebleeding (24-48h)              │
│  • Treat underlying cause:                       │
│     - H. pylori eradication (if ulcer)          │
│     - Stop NSAIDs                               │
│     - Variceal banding/sclerotherapy            │
│  • Consider repeat endoscopy if rebleeds        │
└─────────────────────────────────────────────────┘

Acute/Emergency Management - The First Hour

Immediate Actions (Do Simultaneously):

  1. Resuscitation

    • IV access: Large bore cannulae x2 (16-18G)
    • Fluids: Crystalloid (normal saline or Hartmann's)
    • Blood: Transfuse if Hb <70 (or <80 if cardiac disease) or active bleeding
    • Target: SBP >100, HR <100, adequate urine output
  2. PPI (Proton Pump Inhibitor)

    • Omeprazole: 80mg IV bolus, then 8mg/hour infusion
    • Mechanism: Reduces acid → improves clot stability
    • Evidence: Reduces rebleeding risk
  3. Correct Coagulation

    • If on warfarin: Consider reversal (vitamin K, FFP, prothrombin complex)
    • If on DOACs: Consider reversal agents if available
    • If liver disease: Vitamin K, FFP if bleeding
  4. Nil by Mouth

    • Why: Prepare for endoscopy
    • Duration: Until endoscopy done
  5. Risk Stratification

    • Calculate GBS: Determines urgency
    • Assess stability: BP, HR, ongoing bleeding
    • Plan endoscopy: Urgent vs. routine

Medical Management

PPI Therapy:

DrugDoseRouteDurationNotes
Omeprazole80mg bolus, then 8mg/hourIV infusion72 hoursFirst-line
Pantoprazole80mg bolus, then 8mg/hourIV infusion72 hoursAlternative

Mechanism: Reduces gastric acid → improves clot stability → reduces rebleeding

Evidence: Reduces rebleeding risk by 50-70%

Transfusion Strategy:

IndicationTransfusion ThresholdTarget
Active bleedingTransfuse immediatelyMaintain Hb >80-100
Stable, no cardiac diseaseHb <70 g/LTarget 70-90
Stable, cardiac diseaseHb <80 g/LTarget 80-100
Massive bleedingTransfuse aggressivelyMaintain circulation

Note: Don't over-transfuse (increases portal pressure in varices)

Endoscopic Management

Indications for Endoscopic Therapy:

  • Active bleeding: Spurting or oozing
  • Visible vessel: Non-bleeding visible vessel
  • Adherent clot: After clot removal, if stigmata underneath

Endoscopic Techniques:

TechniqueMechanismSuccess RateNotes
Injection (adrenaline)Vasoconstriction, tamponade80-90%Usually combined with other methods
Thermal (cautery)Coagulates vessel85-95%Bipolar, heater probe
Argon plasma coagulationCoagulates surface80-90%Good for superficial lesions
Mechanical (clips)Clips vessel90-95%Best for visible vessels
CombinationMultiple techniques95%+Usually best approach

Variceal Bleeding:

TechniqueIndicationSuccess Rate
Band ligationEsophageal varices90-95%
SclerotherapyIf banding not possible85-90%
TIPSRefractory bleeding90%+

Interventional Radiology

Angiography + Embolization:

  • Indication: Endoscopy failed, or not possible
  • Technique: Identify bleeding vessel, embolize
  • Success rate: 70-90%
  • Complications: Ischemia, rebleeding

TIPS (Transjugular Intrahepatic Portosystemic Shunt):

  • Indication: Refractory variceal bleeding
  • Mechanism: Reduces portal pressure
  • Success rate: 90%+
  • Complications: Hepatic encephalopathy, shunt stenosis

Surgical Management (Rare)

Indications:

  • Failed endoscopic therapy: Continued bleeding despite endoscopy
  • Massive bleeding: Cannot control endoscopically
  • Perforation: Ulcer perforation
  • Tumor: Bleeding tumor requiring resection

Procedures:

  • Oversewing ulcer: Direct suture of bleeding vessel
  • Gastrectomy: Partial or total (if extensive)
  • Esophageal surgery: If varices or tumor

Disposition

Admit to ICU/HDU If:

  • Hemodynamically unstable
  • Active bleeding
  • High Rockall score (≥6)
  • Post-endoscopic therapy (monitor for rebleeding)

Admit to Ward If:

  • Moderate risk (GBS 3-5)
  • Stable after endoscopy
  • Monitoring needed

Discharge Criteria:

  • Low risk (GBS 0-2)
  • No active bleeding for 24 hours
  • Hb stable
  • Can follow up (endoscopy arranged)
  • Clear plan for H. pylori treatment if needed

Follow-Up:

  • Endoscopy: If not done (routine, 24-48h)
  • H. pylori test: If peptic ulcer (breath test, stool antigen)
  • Medication review: Stop NSAIDs, optimize PPI
  • Warning signs: Return if rebleeding

8. Complications

Immediate (Hours)

ComplicationIncidencePresentationManagement
Hypovolaemic shock20-30%Hypotension, tachycardiaAggressive fluid/blood resuscitation
Rebleeding10-20%Further hematemesis/melenaRepeat endoscopy, consider surgery
Aspiration5-10%During vomitingSuction, may need intubation
Myocardial ischemia5-10%Chest pain, ECG changesTreat shock, consider cardiac workup

Rebleeding:

  • Risk: Highest in first 48-72 hours
  • Signs: Further hematemesis, melena, drop in Hb
  • Management: Repeat endoscopy, may need surgery
  • Prevention: Adequate endoscopic therapy, PPI

Early (Days)

1. Rebleeding (10-20%)

  • Risk factors: High-risk stigmata, varices, large ulcers
  • Management: Repeat endoscopy, consider surgery
  • Prevention: Adequate initial therapy, PPI

2. Infection (5-10%)

  • Aspiration pneumonia: From vomiting
  • Line infections: From IV access
  • Management: Antibiotics, aseptic technique

3. Acute Kidney Injury (10-20%)

  • Cause: Hypovolaemia, contrast (if angiography)
  • Management: Fluid resuscitation, monitor U&Es
  • Prevention: Adequate resuscitation

Late (Weeks-Months)

1. Recurrent Bleeding (10-20%)

  • Risk: Higher if underlying cause not addressed
  • Management: Address cause (H. pylori, stop NSAIDs)
  • Prevention: H. pylori eradication, PPI maintenance

2. Anemia (20-30%)

  • Cause: Blood loss, may be chronic
  • Management: Iron supplementation, may need transfusion
  • Prevention: Adequate initial resuscitation

3. Underlying Condition Progression

  • Ulcers: May recur if H. pylori not treated
  • Varices: May rebleed if portal pressure not controlled
  • Tumors: May progress if malignant

9. Prognosis & Outcomes

Natural History (Without Treatment)

Untreated Upper GI Bleeding:

  • Mortality: 30-40% if massive, untreated
  • Progression: Continued bleeding → hypovolaemic shock → death
  • Time course: Death within hours if massive bleeding untreated

Outcomes with Treatment

VariableOutcomeNotes
In-hospital mortality5-10%Overall; 30-40% in high-risk
30-day mortality8-12%Higher in elderly, comorbidities
Rebleeding rate10-20%Highest in first 48-72h
Need for surgery5-10%If endoscopic therapy fails
Long-term survival80-90% at 1 yearDepends on underlying cause

Factors Affecting Outcomes:

Good Prognosis:

  • Low Rockall score (0-2)
  • Low GBS (0-2)
  • Mallory-Weiss tear (usually self-limited)
  • Young, healthy patient
  • No comorbidities
  • Successful endoscopic therapy

Poor Prognosis:

  • High Rockall score (≥6)
  • High GBS (≥6)
  • Variceal bleeding (higher mortality)
  • Malignancy (bleeding from tumor)
  • Elderly, multiple comorbidities
  • Failed endoscopic therapy
  • Rebleeding

Prognostic Factors

FactorImpact on PrognosisEvidence Level
Rockall scoreEach point increases mortality 1.5xHigh
AgeEach decade increases mortality 1.3xHigh
ComorbiditiesEach comorbidity increases mortality 1.5xHigh
Variceal bleeding2x mortality vs. peptic ulcerHigh
Rebleeding3x mortality if rebleedsHigh
Endoscopic stigmataActive bleeding = worseHigh

10. Evidence & Guidelines

Key Guidelines

1. NICE Guidelines (2012) — UK guidelines for acute upper GI bleeding. National Institute for Health and Care Excellence

Key Recommendations:

  • Risk stratify using GBS
  • Urgent endoscopy for high-risk (GBS ≥3)
  • PPI before and after endoscopy
  • Endoscopic therapy for high-risk stigmata
  • Evidence Level: 1A

2. International Consensus (2019) — International guidelines for non-variceal upper GI bleeding. Gastroenterology

Key Recommendations:

  • Resuscitate before endoscopy
  • Urgent endoscopy (<24h) for high-risk
  • Combination endoscopic therapy
  • High-dose PPI after endoscopy
  • Evidence Level: 1A

3. Baveno VII Consensus (2022) — Guidelines for variceal bleeding. Journal of Hepatology

Key Recommendations:

  • Antibiotic prophylaxis (reduces mortality)
  • Band ligation for esophageal varices
  • TIPS for refractory bleeding
  • Evidence Level: 1A

Landmark Trials

Lau et al. (2000) — High-Dose PPI After Endoscopic Therapy

  • Patients: 240 patients with bleeding peptic ulcers
  • Intervention: High-dose omeprazole vs. placebo after endoscopic therapy
  • Key Finding: Reduced rebleeding (6.7% vs. 22.5%)
  • Clinical Impact: Established PPI after endoscopy
  • PMID: 11058884

Sung et al. (2003) — Combination Endoscopic Therapy

  • Patients: 156 patients with bleeding ulcers
  • Intervention: Injection + thermal vs. injection alone
  • Key Finding: Reduced rebleeding (8% vs. 20%)
  • Clinical Impact: Established combination therapy as standard
  • PMID: 12851875

Evidence Strength

InterventionLevelKey EvidenceClinical Recommendation
PPI before endoscopy1BMeta-analysesReduces need for endoscopic therapy
PPI after endoscopy1AMultiple RCTsReduces rebleeding (Lau trial)
Endoscopic therapy1AMultiple RCTsFor high-risk stigmata
Combination therapy1ARCTsBetter than single method
Urgent endoscopy1BObservationalFor high-risk patients
Antibiotics (varices)1ARCTsReduces mortality

11. Patient/Layperson Explanation

What is Acute Upper GI Bleeding?

Imagine your digestive system as a series of tubes. In acute upper GI bleeding, one of these tubes (your esophagus, stomach, or first part of your small intestine) starts bleeding. You might vomit blood (bright red if fresh, or like coffee grounds if it's been in your stomach) or pass black, tarry stools that look like tar and smell very bad. This happens when something damages the lining of your digestive tract—like an ulcer (a sore), swollen veins (varices), or a tear.

In simple terms: You're bleeding from your stomach or upper intestine, and blood is coming out either when you vomit or in your stools.

Why does it matter?

Acute upper GI bleeding can be serious because you can lose a lot of blood quickly. Your body needs blood to carry oxygen to your organs—without enough blood, your organs can start to fail. Even with the best treatment, about 5-10 out of 100 people don't survive, and this rises to 30-40 out of 100 in people who are already unwell. The good news? Most bleeds stop on their own, and with quick treatment (fluids, blood transfusion if needed, and a camera test to find and treat the cause), most people recover completely.

Think of it like this: It's like a pipe springing a leak—you need to find the leak and fix it before too much water (blood) is lost.

How is it treated?

1. Stopping the Bleeding: Doctors give you fluids and sometimes blood through a drip to replace what you've lost and keep your blood pressure up.

2. Finding the Cause: Doctors do a test called an endoscopy—a thin, flexible camera is passed through your mouth into your stomach to see where the bleeding is coming from. This is done under sedation so you don't feel it.

3. Treating the Bleeding: If the bleeding is still active or looks likely to bleed again, doctors can treat it through the camera:

  • Injections: Medicine injected around the bleeding area
  • Heat treatment: Cautery to seal the bleeding vessel
  • Clips: Small clips to close the bleeding vessel

4. Treating the Underlying Cause:

  • If it's an ulcer: Medicines to reduce acid, antibiotics if infection present
  • If it's varices: Banding (tying off the swollen veins)
  • If it's from medicines: Stop the offending medicine

The goal: Stop the bleeding, find and fix the cause, and prevent it happening again.

What to expect

In the Hospital:

  • First few hours: Doctors will act quickly to stabilize you—fluids, blood if needed, and prepare for the camera test
  • Day 1: You'll have the endoscopy (camera test) to find and treat the bleeding
  • Days 2-3: You'll be monitored closely to make sure the bleeding doesn't start again
  • Days 3-5: If everything is stable, you can usually go home

After Going Home:

  • Medications: You'll need medicines (usually a PPI like omeprazole) to reduce stomach acid and help healing
  • Diet: Usually a normal diet, but avoid alcohol and things that irritate your stomach
  • Follow-up: Doctor visits and sometimes repeat camera tests to make sure everything is healed
  • Lifestyle: Stop smoking, avoid NSAIDs (like ibuprofen), reduce alcohol if that was a factor

Recovery Time:

  • In hospital: Usually 3-5 days
  • At home: Most people feel back to normal within 1-2 weeks
  • Full healing: Ulcers usually heal within 4-8 weeks with treatment

When to seek help

Call 999 (or your emergency number) immediately if:

  • You vomit blood (bright red or coffee-ground)
  • You pass black, tarry stools
  • You feel very weak or faint
  • You feel dizzy or lightheaded
  • Your heart is racing
  • You feel confused or "not yourself"

See your doctor urgently if:

  • You've had upper GI bleeding before and feel unwell again
  • You're taking blood thinners and notice dark stools
  • You have ongoing stomach pain with other symptoms
  • You're losing weight unexpectedly

Remember: If you vomit blood or pass black, tarry stools, don't wait—get emergency help immediately. This can be serious and needs prompt treatment.


12. References

Primary Guidelines

  1. National Institute for Health and Care Excellence. Acute upper gastrointestinal bleeding: management. NICE guideline [CG141]. 2012. NICE

  2. Laine L, Barkun AN, Saltzman JR, et al. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. Am J Gastroenterol. 2021;116(5):899-917. PMID: 33929377

  3. de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959-974. PMID: 35120736

Key Trials

  1. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343(5):310-316. PMID: 11058884

  2. Sung JJ, Tsoi KK, Lai LH, et al. Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut. 2007;56(10):1364-1373. PMID: 17566019

Further Resources

  • NICE Guidelines: National Institute for Health and Care Excellence
  • ACG Guidelines: American College of Gastroenterology
  • Baveno Consensus: Journal of Hepatology
13. Differential Diagnosis

Conditions to Consider

Upper GI bleeding must be distinguished from other causes of blood in vomit or stool:

ConditionKey Distinguishing FeaturesInvestigationManagement Difference
Lower GI bleedingFresh red blood per rectum, no melena, unstableColonoscopy, CT angiogramDifferent source, different endoscopy
Swallowed bloodNosebleed, dental bleeding, no GI symptomsHistory, ENT examinationNo GI intervention needed
HemoptysisCoughing blood, frothy/pink, respiratory symptomsCXR, bronchoscopyRespiratory source, different management
EsophagitisHeartburn, dysphagia, usually chronicOGD shows inflammationPPI, no endoscopic therapy usually
Gastric cancerWeight loss, early satiety, chronic symptomsOGD with biopsyMay need surgery/chemotherapy
Aortoenteric fistulaPrevious aortic surgery, "herald bleed," massive bleedingCT angiogramUrgent vascular surgery
Portal hypertensive gastropathyCirrhosis, chronic anemia, endoscopy shows gastropathyOGDMedical management, TIPS if severe

Clinical Differentiation

Upper vs. Lower GI Bleeding:

FeatureUpper GILower GI
HematemesisYesNo
MelenaYes (usually)Rare (only if slow transit)
HematocheziaOnly if massiveYes
ColorBlack/coffee-groundBright red (usually)
Urea:Creatinine ratio>100Normal
NG aspirateBlood/coffee-groundClear

Hematemesis vs. Hemoptysis:

FeatureHematemesis (GI)Hemoptysis (Respiratory)
MechanismVomitingCoughing
ColorDark red/brownBright red/pink
ConsistencyClots, food mixedFrothy, bubbly
pHAcidic (<4)Alkaline (>7)
SymptomsNausea, abdominal painCough, dyspnoea
InvestigationOGDCXR, bronchoscopy

Mimics & Pitfalls

1. Red Foods/Medications:

  • Beetroot: Can cause red stools (not blood)
  • Food coloring: Red jellies, drinks
  • Medications: Iron (black stools), bismuth (black stools)
  • Test: Stool occult blood test (negative if food)

2. Swallowed Blood:

  • Sources: Nosebleed, dental bleeding, hemoptysis swallowed
  • Clue: No GI symptoms, clear source of bleeding
  • Management: Treat source, no GI investigation needed

3. Aortoenteric Fistula (Don't Miss!):

  • Clue: Previous aortic graft surgery + "herald bleed" (small bleed before massive)
  • Key: High suspicion if any GI bleed post-aortic surgery
  • Investigation: Urgent CT angiogram
  • Management: Urgent vascular surgery (mortality 50%+ if missed)

14. Prevention & Risk Reduction

Primary Prevention (Before First Bleed)

Medication Review in High-Risk Patients:

MedicationAlternative/StrategyRationale
NSAIDsParacetamol, COX-2 inhibitors (if needed)Reduce ulcer risk
AspirinUse lowest effective dose (75mg)Reduce bleeding risk
AnticoagulantsRegular review, monitor INRReduce over-anticoagulation
Dual antiplateletConsider PPI co-prescriptionReduce ulcer bleeding

PPI Co-Prescription:

  • Indication: If high-risk patient on NSAIDs/antiplatelet
  • Drugs: Omeprazole 20mg daily, lansoprazole 30mg daily
  • Evidence: Reduces ulcer bleeding by 60-70%
  • Who: Age >65, previous ulcer, multiple risk factors

H. pylori Screening & Eradication:

  • Who: Before starting long-term NSAIDs, previous ulcer history
  • Test: Stool antigen, breath test, endoscopy biopsy
  • Eradication: Clarithromycin triple therapy (reduces ulcer risk by 90%)

Secondary Prevention (After First Bleed)

Post-Bleeding Management:

InterventionActionDurationEvidence
PPI continuationOmeprazole 20mg daily (or lansoprazole 30mg)Long-term1A
H. pylori eradicationIf positive, full eradication courseOnce (confirm eradication)1A
Stop NSAIDsPermanent if possiblePermanent1A
Aspirin reviewRestart after 3-5 days if cardiovascular indicationAs indicated1B
Anticoagulation reviewRestart when safe (discuss with cardiology)As indicated1B

Aspirin Restarting:

  • Cardiovascular indication (stent, MI, stroke): Restart after 3-5 days
  • Primary prevention only: Consider stopping permanently
  • Always: Use PPI co-prescription if restarting

Anticoagulation Restarting:

  • Timing: Depends on bleeding risk vs. thrombosis risk
  • High thrombosis risk (mechanical valve, AF with high CHADS2): Restart early (3-7 days)
  • Low thrombosis risk: Can wait longer (1-2 weeks)
  • Discuss: Cardiology/hematology input

Tertiary Prevention (Preventing Recurrence)

Lifestyle Modifications:

ModificationRationaleEvidence
Smoking cessationImpairs ulcer healing, increases recurrence1A
Alcohol reductionReduces gastritis, varices risk1B
Avoid NSAIDsDirect ulcer risk1A
Manage stressStress ulcers in high-risk patients1B

Variceal Bleeding Prevention:

  • Non-selective beta-blockers (propranolol, carvedilol): Reduce portal pressure
  • Variceal banding: Elective banding for large varices
  • TIPS: If refractory, repeated bleeding

Regular Follow-Up:

  • Endoscopy: Repeat at 6-8 weeks to confirm healing (if ulcer)
  • H. pylori: Confirm eradication (breath test, stool antigen)
  • Medication review: Ensure PPI compliance, no NSAIDs

15. Special Populations & Considerations

Elderly Patients (>75 Years)

Epidemiology:

  • Incidence: 2-3x higher than younger patients
  • Mortality: 15-20% (vs. 5-10% overall)
  • Presentation: Often atypical (confusion, falls)

Management Considerations:

IssueChallengeApproach
PolypharmacyMultiple medications increasing bleeding riskReview all medications, stop non-essential
ComorbiditiesCardiac, renal, increasing riskCareful fluid balance, transfusion threshold
FrailtyPoor tolerance of proceduresConsider risks vs. benefits
Cognitive impairmentDifficulty with consent, complianceInvolve family, simplified regimens

Treatment Adjustments:

  • Lower transfusion threshold: Hb <80 (vs. <70) if cardiac disease
  • Careful fluid balance: Higher risk of pulmonary oedema
  • Consider goals of care: Early discussions if very frail

Prognosis:

  • Worse than younger patients (mortality 2-3x higher)
  • Higher risk of complications (aspiration, AKI)

Anticoagulated Patients

Warfarin:

INRRiskManagement
1-1.5LowNo reversal needed, proceed with endoscopy
1.5-2.5ModerateGive vitamin K 2-5mg IV, consider FFP if urgent
>2.5HighVitamin K 5-10mg IV + FFP or prothrombin complex concentrate (PCC)

DOACs (Rivaroxaban, Apixaban, Dabigatran):

  • Timing: Note last dose (reversal needed if <24h)
  • Reversal agents:
    • Dabigatran: Idarucizumab (Praxbind)
    • Rivaroxaban/Apixaban: Andexanet alfa (if available)
  • Alternative: Prothrombin complex concentrate (PCC) if specific reversal unavailable

Restarting Anticoagulation:

  • High thrombosis risk: Restart after 3-7 days
  • Low thrombosis risk: Can wait 1-2 weeks
  • Always: Discuss with cardiology/hematology

Cirrhotic Patients (Variceal Bleeding)

Special Considerations:

IssueManagement
CoagulopathyFFP, platelets if active bleeding; vitamin K often ineffective
ThrombocytopeniaTransfuse if <50 and active bleeding
EncephalopathyHigher risk during bleed; lactulose, rifaximin
InfectionAntibiotics prophylaxis (reduces mortality)
Renal dysfunctionCareful fluid balance, avoid nephrotoxins

Variceal-Specific Management:

  • Terlipressin: Reduces portal pressure, start immediately
  • Antibiotics: Ciprofloxacin or ceftriaxone (reduces infection, improves survival)
  • Band ligation: First-line endoscopic therapy
  • TIPS: If refractory bleeding (within 72h if Child-Pugh B/C)

Prognosis:

  • Worse than non-variceal bleeding (mortality 15-25%)
  • Depends on Child-Pugh score (A = 10%, B = 20%, C = 40% mortality)

Chronic Kidney Disease Patients

Challenges:

IssueImpactManagement
Platelet dysfunctionUremic platelets don't work wellDesmopressin (DDAVP) if active bleeding
AnemiaBaseline low HbTransfuse at higher threshold (Hb <80)
Fluid balanceRisk of overloadCareful fluid resuscitation, early dialysis if needed
Contrast exposureRisk of contrast-induced AKIMinimize contrast, hydration

Management Adjustments:

  • Transfusion threshold: Hb <80 (higher than standard)
  • Fluid resuscitation: Cautious, monitor for overload
  • Dialysis: Early if fluid overload despite diuretics
  • Medications: Dose adjust for renal function

Pregnancy

Rare but Important:

CauseManagement
Mallory-Weiss tearSupportive, usually self-limited
Peptic ulcerPPI safe in pregnancy, endoscopy if needed
VaricesRare, manage as non-pregnant but consider fetal monitoring

Medications:

  • Safe: PPIs (omeprazole), sucralfate
  • Avoid: Misoprostol (uterotonic), NSAIDs (late pregnancy)
  • Endoscopy: Safe if needed, second trimester ideal

Multidisciplinary Care:

  • Obstetrics involvement
  • Fetal monitoring if >24 weeks viability
  • Consider delivery if maternal instability threatens fetus

Post-Cardiac Surgery / Stent Patients

Dual Antiplatelet Therapy (DAPT):

  • Recent stent (<6 months drug-eluting, <1 month bare-metal): Very high thrombosis risk
  • Management:
    • Stop aspirin/P2Y12 inhibitor temporarily (if massive bleeding)
    • Restart as soon as possible (ideally <5 days)
    • Discuss with cardiology urgently

Bridge Therapy:

  • Not recommended: Heparin bridging increases bleeding risk
  • Better: Restart oral antiplatelet as soon as endoscopy done

Last Reviewed: 2025-12-24 | MedVellum Editorial Team


Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists. This information is not a substitute for professional medical advice, diagnosis, or treatment.

Last updated: 2025-12-25

At a Glance

EvidenceHigh
Last Updated2025-12-25
Emergency Protocol

Red Flags

  • Hematemesis (vomiting blood)
  • Melena (black, tarry stools)
  • Hemodynamic instability (SBP &lt;90 mmHg)
  • Heart rate &gt;100 bpm
  • Altered mental status
  • Syncope or near-syncope

Clinical Pearls

  • **"Resuscitate first, investigate second"** — Don't delay resuscitation for endoscopy. Get IV access, start fluids, check bloods, then scope. A dead patient can't be scoped.
  • **"Rockall score predicts mortality, Glasgow-Blatchford predicts need for intervention"** — Use Rockall for prognosis, GBS for deciding who needs urgent endoscopy and admission.
  • **Red Flags — Immediate Escalation Required:**
  • - **Hematemesis (vomiting blood)** — Confirms upper GI bleeding
  • - **Melena (black, tarry stools)** — Indicates upper GI source

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines